Innovative Biosensors, Inc. and SecureTeq Corporation Partner to Integrate Technologies for Biodefense Security Management

Rockville, MD, March 3, 2008 – Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, and SecureTeq Corporation, a company providing proprietary software coupled with unique services and solutions for business continuity, commercial and government building security, today announced that they have formed a partnership to integrate and commercialize facility and infrastructure security management systems globally.

IBI’s proprietary BioFlash Biological Aerosol Collection, Detection, and Identification System provides near real-time, specific and sensitive detection of up to 21 biological threat agents in single test or multi-test formats. SecureTeq’s core products offer total integrated solutions for Chemical, Biological, Radiological, Nuclear, Explosive together with Video (CBRNE+V) employing unique proprietary software and “best-in-class” detectors and sensors for the protection of high risk buildings, critical infrastructure, transportation hubs, government and defense facilities.

"SecureTeq’s open architecture solution brings together “best-in-class” threat detection technologies into a single seamless monitoring and management platform and we are excited to have the opportunity to expand the usability of BioFlash by adding this valuable biological detection capability.," said Richard Thomas, IBI’s Vice President of Business Development.

“BioFlash is the only system that has integrated the combination of collection, detection and identification facets and which can be further integrated with the SecureTeq architecture to vastly expand it’s capabilities and the confidence it delivers,” said Anthony D. Bashall SecureTeq’s Executive Vice President, Technology and Corporate Development.

About Innovative Biosensors, Inc.
Innovative Biosensors, Inc. is a privately held company developing novel technologies for the rapid detection of pathogens in biodefense applications and human clinical diagnostics. IBI’s technology has been tailored to rapidly and sensitively detect biological threats in building security, military, and civil defense applications. Additionally, the technology platform is being used to develop rapid tests for the detection of hospital-acquired infections. Additional information is available at

About SecureTeq Corporation
SecureTeq Corporation is privately held and was founded in 2001 by a team of security engineers, computer scientists and former FBI special agents; SecureTeq Corporation was formed to provide leading edge threat detection solutions for private industry, law enforcement and government departments. SecureTeq utilizes proprietary software coupled with “best-in-class” sensors and detectors overlaid with human expertise to Create Intelligence from Data™. SecureTeq provides total solutions to a variety of commercial clients, especially those in the financial community, as well as local, state and federal entities. Using the “best-in-class” CBRNE sensors and detectors from a variety of manufacturers. SecureTeq fully integrates them within its proprietary open architecture SecureTeq FUSION™ software platform that seamlessly integrates with building control and security systems.

This release may contain forward-looking statements that are subject to certain risks and uncertainties, including Innovative Biosensors, Inc.’s mission to develop and commercialize instrument systems, Innovative Biosensors, Inc.’s ability to develop new technologies to conduct rapid diagnosis. Such statements are based on management’s current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Innovative Biosensors, Inc. cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: Innovative Biosensors, Inc.’s expectations that they will incur operating losses in the near future, the early stage of preclinical and clinical testing and trials, uncertainties surrounding the availability of additional funding, Innovative Biosensors, Inc.’s reliance on research collaborations, the actions of competitors and the development of competing technologies, potential patent infringement claims against Innovative Biosensors, Inc.’s products, processes and technologies, Innovative Biosensors, Inc.’s ability to protect their patents and proprietary rights and uncertainties relating to commercialization rights.

Download PDF Download the brochure.

Joe Hernandez
President and CEO
Innovative Biosensors, Inc.
Phone: 301.517.0324

Richard Thomas
Vice President of Business Development
Innovative Biosensors, Inc.

Anthony D. Bashall
Senior Vice President, Marketing & Corporate Development
SecureTeq Corporation
Phone: 617.633.6039

Learn more about Secureteq
Learn more about the markets we serve
  Advisory Board
Learn more about our Advisory Board
  Executive Management Team
Learn about our Management Team
  Employment Oportunities
Explore oppenings at Secureteq
  News and Events
Press releases and other news
SecureTEQ FUSION featured at Milestone's Solution Center booth at ASIS 2009
SecureTeq Corporation Expands its Consulting Business
Secureteq Opens New York City Offices
Home | About Secureteq | Markets | Services and Solutions | Domain Expertise | Support | Contact Us
Copyright 2001-2009 ©Secureteq. All rights reserved.
Terms & Conditions
 |  Privacy Policy